Skip to content

Advertisement

BMC Microbiology

What do you think about BMC? Take part in

Open Access

Cobalamin production by Lactobacillus coryniformis: biochemical identification of the synthetized corrinoid and genomic analysis of the biosynthetic cluster

  • Andrea Carolina Torres1,
  • Verónica Vannini1,
  • Julieta Bonacina1,
  • Graciela Font1,
  • Lucila Saavedra1 and
  • María Pía Taranto1Email author
BMC MicrobiologyBMC series – open, inclusive and trusted201616:240

https://doi.org/10.1186/s12866-016-0854-9

Received: 2 April 2016

Accepted: 27 September 2016

Published: 13 October 2016

Abstract

Background

Despite the fact that most vitamins are present in a variety of foods, malnutrition, unbalanced diets or insufficient intake of foods are still the cause of vitamin deficiencies in humans in some countries. Vitamin B12 (Cobalamin) is a complex compound that is only naturally produced by bacteria and archea. It has been reported that certain strains belonging to lactic acid bacteria group are capable of synthesized water-soluble vitamins such as those included in the B-group, as vitamin B12. In this context, the goal of the present paper was to evaluate and characterize the production of vitamin B12 in Lactobacillus coryniformis CRL 1001, a heterofermentative strain isolated from silage.

Results

Cell extract of L. coryniformis CRL 1001, isolated from silage, is able to correct the coenzyme B12 requirement of Salmonella enterica serovar Typhimurium AR 2680 in minimal medium. The chemical characterization of the corrinoid-like molecule isolated from CRL 1001 cell extract using HPLC and mass spectrometry is reported. The majority of the corrinoid produced by this strain has adenine like Coα-ligand instead 5,6-dimethylbenzimidazole. Genomic studies revealed the presence of the complete machinery of the anaerobic biosynthesis pathway of coenzyme B12. The detected genes encode all proteins for the corrin ring biosynthesis and for the binding of upper (β) and lower (α) ligands in one continuous stretch of the chromosome.

Conclusions

The results here described show for the first time that L. coryniformis subsp. coryniformis CRL 1001 is able to produce pseudocobalamin containing adenine instead of 5,6-dimethlbenzimidazole in the Coα-ligand. Genomic analysis allowed the identification and characterization of the complete de novo biosynthetic pathway of the corrinoid produced by the CRL 1001 strain.

Keywords

Lactobacillus Cobalamin productionCoenzyme B12 gene cluster organization

Background

Lactic acid bacteria (LAB) are a heterogeneous group of bacteria extensively used as starter cultures for the fermented foods development. Because of their metabolism, this group of bacteria can improve the safety, shelf life, nutritional value, flavour and overall quality of fermented products. Some strains have shown to exert a large range of beneficial properties in humans, and they are frequently used as probiotic microorganisms. In addition, certain LAB strains are able to produce and release compounds with biological activity in foods, sometimes referred as nutraceuticals [1]. These micronutrients are used as a cofactor in numerous enzymatic reactions, as it is the case of vitamin B12.

Conceptually, the definition of vitamin B12 generally describes a type of cobalt corrinoid, belonging to the cobalamin (Cbl) group. On the other hand, vitamin B12 is the form of the vitamin obtained during process of industrial production but this form not exists in the nature [2]. Naturally, this compound is found as desoxyadenosilcobalamin (coenzyme B12), methylcobalamin or pseudocobalamin, among other forms. Concerning the structure, the cobalamin molecule present 3 parts main: (i) the central corrinic ring with the four ligands of a cobalt ion, (ii) a superior (or beta) ligand that is attached to adenosyl o methyl group, and (iii) the lower ligand (or alfa), usually dimethylbenzimidazole (DMB). It has been described that in some anaerobic bacteria, the adenine and other ligands can replace DMB giving as a result pseudocobalamin (pseudo-B12) and other active cofactors [3]. This soluble compound is one of the most complex non-polymeric macromolecules produced in the cell and only a reduced group of bacteria and archaea are able to synthesize it. The bacteria present in the rumen of cattle, sheep and other ruminants are the responsible of its synthesis. Humans do not have such microbiota in their large intestine and must absorb the coenzyme from natural sources such as meat, fish, eggs, and pharmaceutical products [4]. A diet sufficient in vitamin B12 is essential to prevent severe pathologies (megaloblastic anaemia, pancytopenia, peripheral neuropathy, increased risk of myocardial infarction and stroke, others) some of which are irreversible [58]. Thus, the use of vitamin-producer bacteria appears as an appropriate alternative to produce innovative foods with added nutritional value [9]. However, the production of vitamin B12 is strain specific and an unusual trait present in certain strains of the Lactobacillus genus. The production of this metabolite by Lactobacillus reuteri strains has been described for the first time by us and confirmed later by others authors [1013]. Moreover, we validated that the corrinoid (pseudo-B12) produced by L. reuteri CRL 1098 is effective in preventing the hematological and neurological pathologies (anaemia, growth retardation, others) caused by a diet deficiency in vitamin B12 in a combined animal model (pregnant mice and their offspring) [14, 15]. More recently, De Angelis et al. [16] described the production and the genetic organization of the complete de novo biosynthetic pathway of vitamin B12 in Lactobacillus rossiae DSM 15814. Among other lactobacilli, previous evidence suggested that two strains of L. coryniformis (CECT 5711 and strain 394) are capable of producing the antimicrobial compound reuterin [17, 18], an enzymatic pathway that involves a cobalamin-dependent enzyme, the glycerol dehydratase [19]. No further analysis related to vitamin B12 production was carried out in those studies. Based on this previous evidence, the purpose of the present study was to evaluate the vitamin B12 production in L. coryniformis CRL 1001, a heterofermentative strain isolated from silage. Firstly, the compound with cobalamin activity was isolated and biochemically characterized. Next, the genome of the CRL 1001 strain was sequenced by whole genome shotgun (WGS) sequencing strategy and the identification of putative biosynthetic operon involved in the synthesis of the corrinoid was performed by in silico analysis. Finally, a detailed comparative study of the cobalamin gene cluster of L. coryniformis CRL 1001 with those of previously known vitamin-producer strains was performed. The results of this research provide the first evidence of vitamin B12 synthesis by a L. coryniformis strain.

Results and discussion

Cobalamin production by L. coryniformis CRL 1001

In order to evidence the production of cobalamin by L. coryniformis CRL 1001, we use S. Typhimurium AR 2680 (metE cbiB) [20] as indicator strain, grown in minimal medium without vitamin B12 according the methodology described by Taranto et al. [12]. The results of the bioassay showed that the cobalamin requirements of the indicator strain were corrected when Cell Extracts (CE) of L. coryniformis CRL 1001 were added; the halo diameter obtained was similar to that obtained with a solution of standard cyanocobalamin (CN-Cbl). On the other hand, no growth was detected when the CE from Lactobacillus plantarum ATCC 8014 (negative control strain) was used. These results would indicate that L. coryniformis CRL 1001 is able to produce compounds with cobalamin activity.

To identify the compound with cobalamin activity produced by L. coryniformis CRL 1001, the CE was analysed by RP-HPLC. The UV-DAD spectra data revealed the presence of two main peaks that showed similar characteristics with the spectrum obtained for the peak belonging to the CN-Cbl standard. The Retention Times (RT) of these peaks were slightly lower (23.77 min and 24.20 min) to the RT of standard solution of CN-Cbl (24.98 min) (Fig. 1). However, when these peaks were collected and analysed using the bioassay, they showed the same ability of vitamin B12 complementation than the CN-Cbl standard. For this reason, we continued with the identification of both peaks.
Fig. 1

RP-HPLC chromatogram of the cell extract (CE) from L. coryniformis CRL 1001 (black); CN-Cbl standard (grey). UV-DAD spectrum and bioassay images (annex inset) of CN-Cbl standard and each corrinoid produced by CRL 1001 strain

Characterization of the corrinoid produced by L. coryniformis CRL 1001

Corrinoid compounds separated by HPLC were analysed by Liquid chromatography–electrospray ionization/tandem mass spectrometry (LC/ESI–MS/MS). The mass module parameters were fine-tuned and optimized with commercial standard of CN-Cbl. The transition 678.3 (m/z) [M + 2H+]++ to 358.7 (m/z) corresponds to the lower ligand, whose DMB is the aglycon attached to ribofuranose 3-phosphate whereas the transition 678.3 (m/z) [M + 2H+]++ to 146.9 (m/z) corresponds to the base DMB. Data transition for pseudo-B12 were estimated and calculated according the bibliography as follows: 672.5 (m/z) [M + 2H+]++ to 347.8 (m/z); this transition corresponds to the lower ligand where adenine is the aglycon attached to ribofuranose 3-phosphate, and the transition 672.5 (m/z) [M + 2H+]++ to 135.9 (m/z) corresponds to the base adenine [21]. Both transitions were sought in the MS and MS/MS spectra of the peaks with cobalamin activity.

The MS spectra of the active peaks obtained by HPLC indicated that a double charged ion with an approximately m/z of 673 [M + 2H+]++ was prominent in the two spectra (Fig. 2). The MS/MS spectrum indicated that the dominant ions with a value approximate m/z 347.8 were attributable to the substitution in the lower ligand where the adenine is the aglycon attached to ribofuranose 3-phosphate.
Fig. 2

Liquid chromatography–electrospray ionization/tandem mass spectrometry (LC/ESI–MS/MS) chromatograms of peaks with cobalamin activity from L. coryniformis CRL 1001. The transitions are shown together (SRMs, 672.5 m/z -- > 136.0 m/z calculated for adenine y 672.5 m/z -- > 348.0 m/z correspond to the lower ligand in which adenine is the aglycon attached to ribofuranose 3-phosphate). Total ion chromatogram (TIC) of the two active peaks, RT 23.77 min (a) and RT 24.20 min (b) and MS/MS spectrum from m/z 660 to 685 of the peak with RT 8.142 min with MS/MS spectrum showing the transitions

The MS showed that the molecular species (corrinoid) synthesized by L. coryniformis CRL 1001 corresponds mainly to Coα-[α-(7-adenyl)]-Coβ-cyanocobamide, commonly known as pseudo-B12, an analogue with a structure very similar to vitamin B12. In this corrinoid, the DMB moiety is substituted by adenine as lower ligand. This compound is a physiologically important form of the vitamin B12 in various microorganisms [22].

The concentration of pseudo-B12 produced by L. coryniformis CRL 1001 was calculated indirectly using a standard curve made with different concentrations of a commercial CN-Cbl. The area of the peaks obtained in the chromatograms corresponds to approximately 0.94 μg mL−1 of pseudo-B12 produced.

Genome identification of vitamin B12 cluster in L. coryniformis CRL 1001

The genome sequence of L. coryniformis CRL 1001 consisted on 133 contigs with a total size of 2,829,178 base pairs and an average GC content of 42 %. The structural and functional annotation performed with the Rapid Annotations using Subsystems Technology (RAST) server [23] allowed us to identify 3341 coding sequences (CDS) and 82 structural RNAs (58 tRNAs) [23]. Additionally, it was observed that 332 subsystems that include the 44 % of the identified CDS are represented in the chromosome.

In silico genomic analyses revealed the presence of 32 open reading frames (ORFs) related to the coenzyme B12 production (cbi, cob, hem and cbl gene cluster) located immediately adjacent to the pdu operon (22 ORFs) which encodes the enzymes necessary for the use of glycerol or propanediol as carbon source (Fig. 3). As described in other species, the close association of these two gene clusters is probably a reflection of the requirements of cobalamin or its corrinoid derivatives for the use of propanodiol [24]. Almost all predicted genes (pdu, cbi, cob and hem) are in the same orientation, except for pocR, which encodes for a transcriptional regulator with 45 % identity and 69 % positive matches at the amino acid level, with its homolog in L. reuteri JCM 1112 [25]. Interestingly, the two clusters (pdu and cbi-cob-hem) have a few intergenic regions and their average G + C content (52 %) differ from that of the draft genome sequence of L. coryniformis CRL 1001 (42 %). As described by Morita et al. [10] for L. reuteri JCM 1112, this data could explain the existence of a genomic island acquired through horizontal gene transfer.
Fig. 3

Schematic representation of the pdu and cbi-cob-hem clusters of L. coryniformis CRL 1001. The arrows represent genes involved in: synthesis of uroporphyrinogen III (dark grey), synthesis of cobinamide, lower ligand and cobalt transport (light grey), propanediol degradation (black) and pocR, a transcriptional regulator (white). On the simplified B12 synthesis pathway scheme, genes encoding proteins involved in synthesis of coenzyme (full lines) and synthesis and transport of intermediaries (incomplete lines) are highlighted

Among pdu genes, pduC, pduD and pduE were found. These genes encode for the three subunits of the glycerol dehydratase, an enzyme that requires cobalamin as a cofactor for performing it catalytic activity [19]. Additionally, a gene coding for the L-threonine kinase PduX, was localized. This protein, described in Salmonella enterica, transfers a phosphoryl group to a free L-threonine and it is involved in de novo synthesis of Adenosyl cobalamin and the assimilation of cobyric acid (Cby) [26].

Downstream of the pdu operon, seventeen cbi genes (cbiA, B, C, D, E, T, F, G, H, J, K, L, M, N, Q, O, and P) and cysG gene were in silico identified. The proteins encoded by these genes are required in most of the reactions that take place in the cell during the corrinoid ring synthesis of the cobalamin molecule [27].

Regarding cob genes cobA, D, U, S and C were found. cobA encodes an adenosyltransferase, a binding protein of adenosyl group as β-ligand [28]. The gene cobD encodes an L-threonine-O-3-phosphate descarboxylase that is involved in the amino-propanol arm synthesis [29] while cob U, S and C encode the proteins that participate in the attachment of the amino-propanol arm and in the assembly of the nucleotide loop that connects the lower cobalt ligand to the corrinoid ring [30].

Finally, downstream of the cbi and cob genes, five hem genes (hem A, C, B, L and D) were detected in a similar way as observed for other microorganisms that produce cobalamin anaerobically [31]. The proteins encoded by these genes are involved in the first steps of the cobalamin biosynthesis, the synthesis of uroporphyrinogen III from L-glutamyl-tRNA(glu). At the same time, the hemD/cobA gene, encoding a single polypeptide with both uroporphyrinogen III synthase and methyltransferase activity was detected [32].

Interestingly, the genome of L. coryniformis CRL 1001 lacks cobT gene, contrary to that observed in the cobalamin biosynthetic cluster of L. reuteri CRL 1098 [11]. Instead, two cbl genes were detected, cblS and cblT, encoding for a α-ribazole phosphoribosyl kinase and a α-ribazole transporter, respectively. These results might suggest an alternative pathway for α-ribazole salvaging and the α-ribazole-P synthesis in L. coryniformis CRL 1001, as it is described in Listeria [33].

In silico comparative analysis of the biosynthetic cluster of vitamin B12

The cobalamin biosynthetic gene cluster has been identified in a few Lactobacillus species, including L. reuteri [11] and more recently in L. rossiae [16]. Both strains are obligate hetero-fermentative LAB [34]. L. coryniformis CRL 1001 is the first facultative heterofermentative strain described as cobalamin producer.

Comparative genomic studies among L. coryniformis CRL 1001, L. reuteri DSM 20016 and L. rossiae DSM 15814 strains evidenced a conserved genetic organization of the coenzyme B12 biosynthetic genes. In these three strains, the cbi-cob-hem cluster is adjacent to the pdu cluster (Fig. 4). However, contrasting other cobalamin producer strains, this two gene sets (pdu and cbi-cob-hem) have an opposite orientation in the L. rossiae genome. Morita et al. [10] suggested that both gene cluster might have been acquired by horizontal transfer and inserted independently in these genomes.
Fig. 4

Linear comparison of the pdu cluster and the cbi-cob-hem cluster between L. coryniformis CRL 1001, L. reuteri DSM 20016 (up) and L. rossie DSM 15814 (down). Genes in the gene clusters are depicted by arrows indicating the transcription direction. Genes conserved between the three genomes are colored in grey and black bars indicating orthologous regions

As previously described for cobalamin producer anaerobic strains, the hem genes were located among the cbi-cob genes in all the organisms under comparison.

The cblS and cblT genes identified in the genome of L. coryniformis were also detected in the genome of L. rossiae where they have an identical localization in the cbi-cob-hem cluster. However, these genes are absent in the genome of L. reuteri. The cobT gene, encoding a Nicotinate mononucleotide (NaMN): base phosphoribosyltransferase, has only been described in this latter specie for the strains L. reuteri CRL 1098 (AY780645.1), L. reuteri JCM 1112 (NC_010609.1) and L. reuteri DSM 20016 (NZ_AZDD00000000.1).

Until now, among the Lactobacillus strains described as cobalamin producers, L. coryniformis CRL 1001 is the only strain harbouring the gene encoding for PduX on its genome (Fig. 4).

A comparative analysis between the deduced amino acid sequences of each ORF included in the vitamin B12 biosynthetic cluster of L. coryniformis CRL 1001 and those from L. rossiae, L. reuteri, Listeria sp. and Salmonella sp. using the BLASTP algorithm, was performed. We found that most of L. coryniformis CRL 1001 proteins have the highest percentage of identity with those identified in L. rossiae strain (Table 1), with the exception of CobD and PduX, which were more similar to Listeria proteins. This result indicates that the amino-propanol phosphate synthesis from L-threonine in L. coryniformis CRL 1001 is similar to that performed by Listeria strains, previously described by Fan et al. [26]. These results suggest an alternative vitamin B12 biosynthetic pathway in this genus.
Table 1

Comparative analysis of the deduced amino acid sequences of each ORF involved in vitamin B12 biosynthesis cluster of Lactobacillus coryniformis CRL 1001 with those present in other cobalamin producer strains

L. coryniformis CRL 1001

Lactobacillus rossiae

Lactobacillus reuteri

Listeria sp.

Salmonella sp.

Protein

Length (aa)

Length (aa)

Identity (%)

Length (aa)

Identity (%)

Length (aa)

Identity (%)

Length (aa)

Identity (%)

CobA

188

189

71

194

68

188

56

176

40

Cb1 T

166

174

61

-*

-*

164

54

192

36

Cob D

360

364

41

362

42

361

45

364

42

Pdu X

288

-*

-*

-*

-*

291

37

288

36

Cbi A

456

457

59

454

61

452

54

459

50

Cbi B

312

319

62

319

58

316

55

459

50

Cbi C

217

213

68

228

64

210

64

210

51

Cbi D

365

375

74

383

73

373

55

370

50

Cbi E

199

200

54

199

55

198

53

201

43

Cbi T

184

188

56

184

63

189

53

192

44

Cbi F

254

258

83

253

77

249

76

257

71

Cbi G

351

355

55

351

53

343

46

351

36

Cbi H

241

241

77

241

78

241

67

241

58

Cbi J

249

250

47

252

56

250

45

263

33

Hem D/Cob A

449

468

45

464

48

493

40

-*

-*

Cbi K

262

259

47

259

53

261

49

264

46

Cbi L

235

232

47

232

62

236

48

237

38

Cbi M

248

239

77

247

74

244

59

245

57

Cbi N

104

114

76

103

63

82

56

93

45

Cbi Q

235

230

54

225

56

225

37

225

34

Cbi O

276

274

65

269

63

268

54

271

51

Cbi P

499

499

67

503

70

511

57

506

56

Cys G

153

148

45

152

51

146

44

154

32

Hem A

429

431

53

421

55

-

-

-

-

Hem C

305

309

55

305

55

-

-

-

-

Hem B

324

321

81

323

77

-

-

-

-

Hem L

430

430

77

431

75

-

-

-

-

Cbl S

242

252

53

-*

-*

252

38

273

37

Cob U

196

197

46

196

54

185

41

181

40

Cob S

253

257

52

253

53

248

38

244

35

Cob C

194

194

46

196

43

191

32

202

29

Hem D

209

243

46

236

49

-

-

-

-

Length variation among deduced aminoacid sequences of each ORF related to cobalamin production in Lactobacillus, Salmonella and Listeria strains. The percentage of protein sequence identity is related to those detected in Lactobacillus coryniformis CRL1001. (-*) ORF not detected. (-) ORF not detected among cbi-cob-hem cluster

Conclusion

In this work, we demonstrated for the first time that L. coryniformis subsp. coryniformis CRL 1001 is able to produce corrinoids with cobalamin activity. The chemical characterization of the molecule isolated from CRL 1001 CE using HPLC and mass spectrometry show that the majority of corrinoid produced is pseudocobalamin that has adenine like Coα-ligand instead 5,6-dimethylbenzimidazole. This molecule is one of the forms of coenzyme B12 occurring in nature. Genomic studies revealed the presence of the complete anaerobic biosynthetic pathway of coenzyme B12. The comparative analysis of the cobalamin gene cluster of L. coryniformis CRL 1001 with those present in strains previously described as vitamin producers, revealed that this strain bears the genes cblS-cblT only present in the genome of L. rossiae DSM 15814. Moreover, pduX gene has not been detected in another strain of the Lactobacillus genus. The results of this work provide the first evidence of vitamin B12 synthesis by a L. coryniformis strain.

Methods

Strains, media and culture conditions

L. coryniformis CRL 1001, a strain originally isolated from silage, belongs to the CERELA-CONICET culture collection. The CRL 1001 strain was grown in Man-Rogosa-Sharpe (MRS) broth and Vitamin B12 Assay Medium (Merck, Germany) overnight at 37 °C without shaking. S. Typhimurium AR 2680, a strain with mutations in the genes metE and cbiB, was used as indicator strain in bioassays for cobalamin determination. This strain was grown in Luria-Bertani (LB) broth at 37 °C with aeration. To perform the bioassay, the indicator strain was grown in minimal A medium (NaCl, 0.5 g L−1, Na2HPO4, 6 g L−1; KH2PO4, 3 g L−1, NH4Cl 1 g L−1; glucose, 4 g L−1; MgSO4, 2 mM, CaCl2 0.1 mM). As negative control, L. plantarum ATCC 8014 was employed.

Preparation of cultures and cell-extracts

The production of corrinoid type-cobalamin by L. coryniformis CRL 1001 was detected as following: a culture was inoculated duplicated in vitamin B12-free assay medium, grown at 37 °C for 16 h and subcultured three times in the same medium before use. Cell Extracts (CE) were prepared from 100 mL of culture grown for 24 h; after harvesting (8000 × g, 5 min), cells were washed in 10 mL of 0.1 M phosphate buffer pH 7.0 twice and resuspended in 10 mL of the same buffer and were fasted overnight at 2 °C. Cells were harvested (8000 × g, 5 min) and resuspended in 10 mL of extraction buffer (0.1 M Na2HPO4, pH 4.5 reached with, 0.005 % KCN). The cell suspension obtained was autoclaved at 120 °C for 20 min, the pellet was separated by centrifugation (10,000 × g, 20 min), and the supernatant was passed over a solid-phase extraction (SPE) column C18-E (Phenomenex) with 500 mg particle size and 6 mL reservoir volume; the column was previously activated with 6 mL of methanol HPLC degree (Loba Chemie, India). The column was washed with 2 volumes of ultra-purified water twice to remove salts and other hydrophilic contaminants. The potentials corrinoid was eluted with 1 volume of methanol and concentrated to dryness in vacuum at 30 °C. The residue was dissolved in 100 μl of 50 % methanol and stored in the dark at - 20 °C until use.

Cobalamin detection

To demonstrate the production of cobalamin by L. coryniformis CRL 1001, a bioassay using S. Typhimurium AR 2680 as indicator strain was performed. The CE from L. coryniformis CRL 1001 was examined for its ability to correct the cobalamin requirement of the AR 2680 strain in minimal medium. For this purpose, S. Typhimurium AR 2680 cells were grown for 16 to 18 h in LB medium; the active culture was seeded onto minimal agar medium specific for this strain. Four wells were performed in each agar plate. Fifteen microliters of CE from L. coryniformis CRL 1001 (dilutions 1 10−1 and 1 100−1) were loaded in each well and incubated 24 h under anaerobic conditions at 37 °C. As comparative standard of vitamin B12, a commercial cianocobalamin (CN-Cbl) solution (0.5 μg mL−1) (Sigma-Aldrich, cod. V2876) was used. The CE of L. plantarum ATCC 8014, obtained in a similar way that the CE of L. coryniformis CRL 1001, was used as negative control.

Isolation and characterization of the corrinoid

To isolate the corrinoid produced by L. coryniformis CRL 1001, the CE was loaded onto a C18 solid-phase 5 μm extraction column (250 × 4.6 mm) (Shimadzu Shim-Pack VP-ODS) and purified by reverse-phase (RP)-HPLC using a LC_20 AT system automated gradient controller with a SIL-20ª HT autosampler and a SPD-M20A diode array UV–visible detector at 361 nm (Shimadzu Corporation, Kyoto, Japan). The column was thermostated at 25 °C. The mobile phases was filtered through a 0.22 μm membrane filter and vacuum degassed prior to use. The mobile phases were prepared with ultra-purified water with 0.1 % formic acid (Solvent A) and methanol with 0.1 % (v/v) formic acid (Solvent B).

The protocol used was described by Yu et al. [35] with some modifications. The following mobile phase gradients (Solvent B) were used: 0–2 min (20 %); 2–5 min (35 %); 5–22 min (100 %); 22–26 min (100 %); 26–36 min (20 %); and 36–45 min (5 %); this step was followed by the final passage of Solvent B at 5 % for re-optimization of the parameters in the module HPLC. The volume of injection was 100 μl. The HPLC was operated in a constant flow mode and the flow rate was kept at 0.5 ml min−1.

The peaks with RT close to the RT of CN-Cbl standard (Sigma-Aldrich, cod. V2876) (concentration = 5 μg mL−1) were collected and concentrated to dryness under vacuum at 30 °C. Then, the peaks were dissolved with methanol 50 % and stored in the dark at - 20 °C until use. The vitamin B12 activity of each collected peak at 1.10−1 and 1.100−1 dilutions was detected using the bioassay with the Salmonella strain. Peaks with vitamin B12 activity positive were analysed by mass spectrometry.

The active peaks collected from the RP-HPLC were analysed using Ultimate 3000 RSLC Dionex - Thermo Scientic with a C18 column 50 × 2.1 mm that contained 1.9 micron particles (Hypersil-GOLD). The solvents for Liquid Chromatography were solvent A (ultra-purified water with 0.1 % formic acid) and solvent B (methanol with 0.1 % formic acid). The flow rate was 0.2 mL min−1 and the injection volume was 10 μL. Chromatography was in gradient, and the solvent composition was chosen such that the compound of interest eluted 8–9 min after injection. The mobile phase gradients (solvent B) were maintained during a 35 min run: 0–2 min (5 %); 2–5 min (35 %); 5–22 min (100 %); 22–24 min (100 %); 24–28 min (5 %); and 28–35 min (5 %), this step was followed by 50 % of solvent B for re-optimization of the parameters in the module HPLC coupled with Mass. A single peak for each sample was eluted and the area of the signal was used for quantitative analysis. Positive-ion MS/MS experiments were performed in product mode on a triple quadrupole mass spectrometer (Thermo Scientific TSQ Quantum Access Max).

Genome sequencing

The genomic DNA was extracted from the cultured bacterium according to Pospiech and Neuman [36] and the genome sequence was determined using a whole-genome shotgun (WGS) strategy with an Ion Torrent personal genome machine (Life Technologies). Quality filtered reads were in silico assembled via the DNASTAR NGen assembler by MR DNA (Shallowater, TX).

This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession LNUL00000000. The version described in this paper is LNUL01000000.

Genomic analysis

The L. coryniformis CRL 1001 genome sequence analysis was carried out following different approaches. Open Reading Frame (ORF) prediction and functional assignment was automatically performed using the RAST webserver (http://rast.nmpdr.org/), ORF Finder (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) and BLASTX (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The classification of the ORFs was carried out using BLASTP alignment against the database (http://blast.ncbi.nlm.nih.gov/Blast.cgi), using a cut-off E-value of 1.10−4 with at least 30 % of identity across a minimum of 50 % of a given protein length.

Comparative analyses

BLAST-based comparative analyses were performed of each one of the CDS of the cbi-cob-hem cluster between L. coryniformis CRL 1001 and two well-characterized Lactobacillus strains described as corrinoids compound producers with cobalamin activity, L. reuteri DSM 20016 and L. rossiae DSM 15814. This analysis was performed employing Easyfig 2.1: a genome comparison visualizer application [37].

Declarations

Acknowledgements

We thank Dr. Gastón Pourrieux (Centro de Referencia para Lactobacilos, CERELA-CONICET, Argentina) for the technical support with HPLC and spectrometry studies.

Funding

This study was carried out with the financial support from CONICET (PIP0406/12) and MinCyT (PICT2011 N°0175) from Argentina.

Availability of data and materials

Whole Genome Shotgun project of Lactobacillus coryniformis CRL 1001 has been deposited at DDBJ/EMBL/GenBank under the accession LNUL00000000. The version described in this paper is LNUL01000000.

Authors’ contributions

ACT carried out biochemical and molecular genetic studies, participated in the drafted the manuscript. MVV participated physiological and genetic studies. JB participated in the genomic and comparative analysis. GF participated in the discussion of the study and performed the statistical analysis. LS participated in the design, discussion and coordination of this study and drafting the manuscript. MPT carried out the coordination of this study and participated in the design, discussion and drafting the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Centro de Referencia para Lactobacilos (CERELA)-CONICET

References

  1. Wildman REC, Wildman R, Wallace TC. Handbook of Nutraceuticals and Functional Foods. 2nd ed. 2006.View ArticleGoogle Scholar
  2. Rucker RB, Suttie JW, McCormick DB. Handbook of Vitamins. 3rd ed. 2001.Google Scholar
  3. Martens JH, Barg H, Warren MJ, Jahn D. Microbial production of vitamin B12. Appl Microbiol Biotechnol. 2002;58(3):275–85.View ArticlePubMedGoogle Scholar
  4. Herbert V. Prooxidant effects of antioxidant vitamins. Introduction. J Nutr. 1996;126(4 Suppl):1197S–200.PubMedGoogle Scholar
  5. Derin S, Koseoglu S, Sahin C, Sahan M. Effect of vitamin B12 deficiency on olfactory function. Int Forum Allergy Rhinol. 2016;6:1051–55.Google Scholar
  6. Kocaoglu C, Akin F, Caksen H, Boke SB, Arslan S, Aygun S. Cerebral atrophy in a vitamin B12-deficient infant of a vegetarian mother. J Health Popul Nutr. 2014;32(2):367–71.PubMedPubMed CentralGoogle Scholar
  7. von Schenck U, Bender-Gotze C, Koletzko B. Persistence of neurological damage induced by dietary vitamin B-12 deficiency in infancy. Arch Dis Child. 1997;77(2):137–9.View ArticleGoogle Scholar
  8. Issac TG, Soundarya S, Christopher R, Chandra SR. Vitamin B12 deficiency: an important reversible co-morbidity in neuropsychiatric manifestations. Indian J Psychol Med. 2015;37(1):26–9.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Hugenholtz J, Smid EJ. Nutraceutical production with food-grade microorganisms. Curr Opin Biotechnol. 2002;13(5):497–507.View ArticlePubMedGoogle Scholar
  10. Morita H, Toh H, Fukuda S, Horikawa H, Oshima K, Suzuki T, Murakami M, Hisamatsu S, Kato Y, Takizawa T, et al. Comparative genome analysis of Lactobacillus reuteri and Lactobacillus fermentum reveal a genomic island for reuterin and cobalamin production. DNA Res. 2008;15(3):151–61.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Santos F, Vera JL, van der Heijden R, Valdez G, de Vos WM, Sesma F, Hugenholtz J. The complete coenzyme B12 biosynthesis gene cluster of Lactobacillus reuteri CRL 1098. Microbiology. 2008;154(Pt 1):81–93.View ArticlePubMedGoogle Scholar
  12. Taranto MP, Vera JL, Hugenholtz J, De Valdez GF, Sesma F. Lactobacillus reuteri CRL 1098 produces cobalamin. J Bacteriol. 2003;185(18):5643–7.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Sriramulu DD, Liang M, Hernandez-Romero D, Raux-Deery E, Lunsdorf H, Parsons JB, Warren MJ, Prentice MB. Lactobacillus reuteri DSM 20016 produces cobalamin-dependent diol dehydratase in metabolosomes and metabolizes 1,2-propanediol by disproportionation. J Bacteriol. 2008;190(13):4559–67.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Molina VC, Medici M, Taranto MP, Font de Valdez G. Lactobacillus reuteri CRL 1098 prevents side effects produced by a nutritional vitamin B deficiency. J Appl Microbiol. 2009;106(2):467–73.View ArticlePubMedGoogle Scholar
  15. Molina V, Medici M, Font de Valdez G, Taranto MP. Soybean-based functional food with vitamin B12-producing lactic acid bacteria. J Funct Foods. 2012;4(4):831–6.View ArticleGoogle Scholar
  16. De Angelis M, Bottacini F, Fosso B, Kelleher P, Calasso M, Di Cagno R, Ventura M, Picardi E, van Sinderen D, Gobbetti M. Lactobacillus rossiae, a vitamin B12 producer, represents a metabolically versatile species within the Genus Lactobacillus. PLoS One. 2014;9(9):e107232.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Martin R, Olivares M, Marin ML, Xaus J, Fernandez L, Rodriguez JM. Characterization of a reuterin-producing Lactobacillus coryniformis strain isolated from a goat’s milk cheese. Int J Food Microbiol. 2005;104(3):267–77.View ArticlePubMedGoogle Scholar
  18. Tanaka O, Komatsu T, Oshibe A, Cai Y, Miyazaki S, Nakanishi K. Production of 3-hydroxypropionaldehyde in silage inoculated with Lactobacillus coryniformis plus glycerol. Biosci Biotechnol Biochem. 2009;73(7):1494–9.View ArticlePubMedGoogle Scholar
  19. Daniel R, Bobik TA, Gottschalk G. Biochemistry of coenzyme B12-dependent glycerol and diol dehydratases and organization of the encoding genes. FEMS Microbiol Rev. 1998;22(5):553–66.View ArticlePubMedGoogle Scholar
  20. Raux E, Lanois A, Levillayer F, Warren MJ, Brody E, Rambach A, Thermes C. Salmonella typhimurium cobalamin (vitamin B12) biosynthetic genes: functional studies in S. typhimurium and Escherichia coli. J Bacteriol. 1996;178(3):753–67.PubMedPubMed CentralGoogle Scholar
  21. Hashimoto E, Yabuta Y, Takenaka S, Yamaguchi Y, Takenaka H, Watanabe F. Characterization of corrinoid compounds from edible cyanobacterium Nostochopsis sp. J Nutr Sci Vitaminol. 2012;58(1):50–3.View ArticlePubMedGoogle Scholar
  22. Taga ME, Walker GC. Pseudo-B12 joins the cofactor family. J Bacteriol. 2008;190(4):1157–9.View ArticlePubMedGoogle Scholar
  23. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Bobik TA, Havemann GD, Busch RJ, Williams DS, Aldrich HC. The propanediol utilization (pdu) operon of Salmonella enterica serovar Typhimurium LT2 includes genes necessary for formation of polyhedral organelles involved in coenzyme B(12)-dependent 1, 2-propanediol degradation. J Bacteriol. 1999;181(19):5967–75.PubMedPubMed CentralGoogle Scholar
  25. Santos F, Spinler JK, Saulnier DM, Molenaar D, Teusink B, de Vos WM, Versalovic J, Hugenholtz J. Functional identification in Lactobacillus reuteri of a PocR-like transcription factor regulating glycerol utilization and vitamin B12 synthesis. Microb Cell Fact. 2011;10:55.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Fan C, Bobik TA. The PduX enzyme of Salmonella enterica is an L-threonine kinase used for coenzyme B12 synthesis. J Biol Chem. 2008;283(17):11322–9.View ArticlePubMedGoogle Scholar
  27. Raux E, Lanois A, Rambach A, Warren MJ, Thermes C. Cobalamin (vitamin B12) biosynthesis: functional characterization of the Bacillus megaterium cbi genes required to convert uroporphyrinogen III into cobyrinic acid a, c-diamide. Biochem J. 1998;335(Pt 1):167–73.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Suh S, Escalante-Semerena JC. Purification and initial characterization of the ATP:corrinoid adenosyltransferase encoded by the cobA gene of Salmonella typhimurium. J Bacteriol. 1995;177(4):921–5.PubMedPubMed CentralGoogle Scholar
  29. Brushaber KR, O’Toole GA, Escalante-Semerena JC. CobD, a novel enzyme with L-threonine-O-3-phosphate decarboxylase activity, is responsible for the synthesis of (R)-1-amino-2-propanol O-2-phosphate, a proposed new intermediate in cobalamin biosynthesis in Salmonella typhimurium LT2. J Biol Chem. 1998;273(5):2684–91.View ArticlePubMedGoogle Scholar
  30. Maggio-Hall LA, Escalante-Semerena JC. In vitro synthesis of the nucleotide loop of cobalamin by Salmonella typhimurium enzymes. Proc Natl Acad Sci U S A. 1999;96(21):11798–803.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Johansson P, Hederstedt L. Organization of genes for tetrapyrrole biosynthesis in gram--positive bacteria. Microbiology. 1999;145(Pt 3):529–38.View ArticlePubMedGoogle Scholar
  32. Vannini V, Rodriguez A, Vera JL, de Valdez GF, Taranto MP, Sesma F. Cloning and heterologous expression of Lactobacillus reuteri uroporphyrinogen III synthase/methyltransferase gene (cobA/hemD): preliminary characterization. Biotechnol Lett. 2011;33(8):1625–32.View ArticlePubMedGoogle Scholar
  33. Gray MJ, Escalante-Semerena JC. A new pathway for the synthesis of alpha-ribazole-phosphate in Listeria innocua. Mol Microbiol. 2010;77(6):1429–38.View ArticlePubMedPubMed CentralGoogle Scholar
  34. De Vos P, Garrity GM, Jones D, Krieg NR, Ludwig W, Rainey FA, Schleifer K, Whitman WB. The firmicutes. In: Parte AC, editor. Bergey’s manual of systematic bacteriology second edition, vol. Three. 2nd ed. New York: Springer Science + Business Media; 2009.Google Scholar
  35. Yu Y, Zhu X, Shen Y, Yao H, Wang P, Ye K, Wang X, Gu Q. Enhancing the vitamin B12 production and growth of Propionibacterium freudenreichii in tofu wastewater via a light-induced vitamin B12 riboswitch. Appl Microbiol Biotechnol. 2015;99(24):10481–8.View ArticlePubMedGoogle Scholar
  36. Pospiech A, Neumann B. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends Genet. 1995;11(6):217–8.View ArticlePubMedGoogle Scholar
  37. Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27(7):1009–10.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement